Extensive-stage Small Cell Lung Cancer (SCLC)
Oncology·MeSH: Small Cell Lung Carcinoma
Prevalence
6.0 / 100K
Incidence
8.0 / 100K/yr
2 drugs in development·1 company·0 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Extensive-stage Small Cell Lung Cancer (SCLC)?
BioSniper tracks 2 drugs in development for Extensive-stage Small Cell Lung Cancer (SCLC) across 1 company.
What is the prevalence of Extensive-stage Small Cell Lung Cancer (SCLC)?
The estimated prevalence of Extensive-stage Small Cell Lung Cancer (SCLC) is approximately 6.0 per 100,000 population.
Deep-dive into Extensive-stage Small Cell Lung Cancer (SCLC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis